logo

Quick Facts

Share

AstraZeneca Plc (AZN.L, AZN) announced Monday that Lynparza (olaparib), jointly developed by the company and Merck & Co., Inc. (MRK), has been recommended for approval in the European Union for treating prostate cancer as well as Ovarian Cancer. The Committee for Medicinal Products for Human Use or...

Superdry Plc (SDRY.L, SEPGF.PK, SEPGY.PK) reported a statutory loss before tax of 166.9 million pounds for the 52 weeks ending 25 April 2020 compared to a loss of 89.3 million pounds, previous year. Loss per share was 174.1 pence compared to a loss of 123.9 pence. Statutory loss before tax included a...

Costa Cruises, a part of Carnival Corporation & plc (CCL, CCL.L, CUK), announced that Costa Diadema will depart from Genoa on September 21. Costa Diadema's itinerary, which marks the return of Costa's cruise holidays to Liguria and the Western Mediterranean, only includes calls at Italian ports and is...

Security company G4S plc (GFSZY.PK, GFS.L) Monday said its revenues have remained resilient through the first eight months of the year 2020, following a strong performance in the first half. Underlying earnings, which were in line with 2019 at the six months stage, are now ahead of the prior year...

Alexion Pharmaceuticals, Inc. (ALXN) announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending marketing authorization in the European Union for a new 100 mg/mL intravenous advanced formulation of ULTOMIRIS (ravulizumab). The company noted that the...

Nikola Corp. (NKLA) announced the appointment of Stephen Girsky, former Vice Chairman of General Motors Co. and a member of Nikola's Board, as Chairman of the Board, effective immediately. The Board has accepted the proposal by Trevor Milton to voluntarily step aside as Executive Chairman and from the...

Garrett Motion Inc. (GTX) said that it has commenced voluntary Chapter 11 cases with the United States Bankruptcy Court for the Southern District of New York. KPS Capital Partners agreed to acquire substantially all of the assets of Garrett Motion for about $2.1 billion. In connection with its...

Rolls-Royce Holdings plc (RYCEF.PK, RR.L, RYCEY.PK) said it is seeking to raise up to 2.5 billion pounds to strengthen its balance sheet, through a variety of options including a rights issue, new debt issue and other forms of equity issuance. Rolls-Royce notes the continued media speculation regarding...

Roche (RHHBY) said Friday that the European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP has recommended the approval of Tecentriq in combination with Avastin for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma or HCC who have...

Myers Industries, Inc. (MYE) announced the appointment of Dan Hoehn as Interim Chief Financial Officer, effective September 18, 2020. This follows the mutual agreement of the company and Kevin Brackman, former Executive Vice President and Chief Financial Officer, to separate. Hoehn has served as the...

Arthur J. Gallagher & Co. (AJG) announced the acquisition of Erin P. Collins & Associates, Inc., an employee benefits and workplace wellbeing consultant serving clients throughout the state of Arizona from offices in Kingman and Phoenix. The company said Erin Collins and his associates will continue...

United States Steel Corp. (X) announced the company expects its third quarter adjusted loss per share to be approximately $1.45. On average, nine analysts polled by Thomson Reuters expect the company to report a loss per share of $1.53, for the quarter. Analysts' estimates typically exclude special items. For...

Immunomedics Inc. (IMMU) said Friday that early-stage clinical results with Trodelvy in brain cancers were encouraging. The results include partial responses in small cohort of patients with brain metastasis from breast cancer (BMBC) and recurrent glioblastoma (rGBM). Immunomedics noted that Trodelvy...

Cubic Corp. (CUB) announced Friday that it's Cubic Mission and Performance Solutions (CMPS) business division has been awarded a contract to continue delivering support for its P5 Combat Training System (P5CTS) for the U.S. Air Force (USAF) and a number of international partners currently using the system. The...

Mirati Therapeutics, Inc. (MRTX) announced updated clinical results from its Phase 2 study evaluating sitravatinib in combination with nivolumab in patients with advanced or metastatic urothelial carcinoma. The company said the combination of sitravatinib with nivolumab showed promising clinical activity...

Follow RTT